comparemela.com
Home
Live Updates
Turn Biotechnologies - Breaking News
Pages:
5
6
7
8
9
10
11
Latest Breaking News On - Turn biotechnologies - Page 4 : comparemela.com
Turn Biotechnologies Sharpens Immunology Focus by Adding Two Cell Therapy Specialists to its Medical Advisory Board
/PRNewswire/ Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced the.
United states
Jim martinez
Anja krammer
Kevinj curran
Memorial sloan kettering cancer center
American society of pediatric hematology oncology
Business development finance committee
Stem cell engineering committee
National cancer institute
American society of hematology
Howard hughes medical institute
International society of cell gene therapy
Dysregulation program
Medical advisory
Sloan kettering cancer center
Joseph hai oved
Turn Biotechnologies to Present at the Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
/PRNewswire/ Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced.
Jim martinez
Anja krammer
Turn biotechnologies
Chief executive officer
Guggenheim healthcare talks
Genomic medicines
Rare disease days
Epigenetic reprogramming
Delivery platform
Turn Biotechnologies, Inc : Turn Biotechnologies Introduces its Dermatology Platform to the European Aesthetic Community at AMWC
MOUNTAIN VIEW, Calif., March 30, 2023 /PRNewswire/ Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, announced
Vittorio sebastiano
Jim martinez
World congress
World congress on
Grimaldi forum
Turn biotechnologies
Anti aging world congress
Turn bio
Epigenetic reprogramming
Camille blanc auditorium
Turna delivery platform
Turn Biotechnologies to Present at Next Generation CAR & T Cell Therapies Conference on February 28
/PRNewswire/ Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today will.
Mustafa turkoz
Jim martinez
Bioprocess international
San diego convention center
Turna delivery platform
Turn bio immunology
Epigenetic reprogramming enhances
T cell proliferation
Upper level
Next generation
Cell therapies conference
Epigenetic reprogramming
Delivery platform
Turn biotechnologies
Pfizer Invests $4 1 Million In Decentralized Science Organization VitaDAO Fundraising Round
Pfizer Ventures, a subsidiary of global pharmaceutical giant Pfizer,participated in a $4.1 million investment round from VitaDAO
Balaji srinivasan
Michael baran
University of copenhagen
Stanford university
Pfizer ventures
Shine capital
Potential to revolutionize scientific funding
Turn biotechnologies
vimarsana © 2020. All Rights Reserved.